Fol News

Tutti gli approfondimenti
Tutte le notizie

Tsoi 0,0075

  • Trading Day 19 aprile Torino - Corso Gratuito sull'investimento

    Migliora la tua strategia di trading con le preziose intuizioni dei nostri esperti su oro, materie prime, analisi tecnica, criptovalute e molto altro ancora. Iscriviti subito per partecipare gratuitamente allo Swissquote Trading Day.

    Per continuare a leggere visita questo LINK
ciao fernando>>>>>

si si la conosco
per un motivo....

il secondo lavora con regen
______________________
Thomas Ichim
anche questo si conosce bene





Notice the management names with CAPO

are a lot of TSI/TSOI peeps

DIRECTOR AND EXECUTIVE OFFICERS

Timothy G. Dixon – Chairman of the Board of Directors
Harry M. Lander – Chief Executive Officer, Director
Gerry B. Berg – Chief Financial Officer, Director
Michael Agadjanyan – Chief Scientific Officer, Director
Thomas Ichim – Director
Nikolai Petrovsky – Director
Ara Kocharyan – Director
Anahit Ghochikyan – Director

http://capotherapeutics.com/?page_id=171
 
Ciao Max, grazie per la risposta.
Tutto bene tra la Lombardia e Liguria?


con TSOI sembrerebbe si possa andare long. che ne pensi?
tu hai una posizione aperta?
in fin dei conti il flottante è veramente irrisorio e tra l'altro non è aumentato nell'ultimo anno.

PS: 2 domande
1) che idea hai riguardo al fatto che Ichim a inizio anno si è dimesso dal Board Regen ( ufficialmente per motivi di salute) per entrare in quello di TSOI?
forse che ha litigato con Koos?
2) Capo Scientific ( attualmente non quotata) sembra una società dalle potenzialità mostruose, non pare anche a te?

Ciao , MITICO:bow:
 
TSOI Highligths from yesterday filing:
A/S : 699 millions ( unch )
O/S: 682 millions ( unch)
TSOI own Nutraceutical Division (brevetto del ProJuvenol)
As of July 20, 2016 TSI owns approximately 6.5% of the outstanding shares of CAPO
As of July 20, 2016 TSI owns approximately 73.75% of the outstanding shares of Omnibiome (OMNI)
As of July 20, 2016 TSI owns approximately 21.5% of the outstanding shares of MVAX

The Officers and Directors of TSOI are also officers and Directors of CAPO, OMNI and MVAX

nelle ultime settimane ho incrementato a 0.005 e 0.006...media attuale 0,0064
 
MAX,ciao.
Tu sai qualcosa sulla tempistica della quotazione di CAPO?
Per caso se dentro anche in TSOI?
 
ho letto adesso il tuo post
molto interessante

da studiare!!!!
 
quando hai finito gli studi :read:, fammi sapere che ne pensi!
....se è il caso di lasciar perdere o incrementare pesante.....
ciao mitico!
 
:o


Therapeutic Solutions International, Inc. | Facebook


http://appft.uspto.gov/netacgi/nph-...01".PGNR.&OS=DN/20160324801&RS=DN/20160324801


We are very excited to see that our patent for ProJuvenol has published.

We are pleased to inform you that the above-referenced U.S. patent application published on November 10, 2016 under Publication No. US 2016/0324801. Copies of the Notice of Publication and Publication are provided. The purpose of the publication is to inform the public of the existence of the application and to provide the owner of the application with certain provisional rights. The publication does not provide the right to enforce the patent. Nevertheless, once a patent is issued, the provisional rights may permit the patent owner, under certain circumstances, to claim compensation from others who use the claimed invention in the United States after the publication date without authorization.
 
0,0022-0,0023 siamo quasi sui minimi assoluti....

qualcuno ha news, riguardo questo titolo ? :confused:
 
questa è una grande azienda....
secondo me nel prossimo futuro, (breve termine) quoterà al NASDAQ...


Therapeutic Solutions International, Inc.

is a public company focused on immune
modulation for the treatment of several specific diseases.

NEWS 6/6/18

Therapeutic Solutions International Announces Licensing of Additional Technologies to
Pan American Cancer Treatment Center

Therapeutic Solutions International Announces Licensing of Additional Technologies to Pan American Cancer Treatment Center

link to Pan Am Video:

Pan Am Cancer treatment center tour - YouTube

OCEANSIDE, CA -- June 06, 2018 -- InvestorsHub NewsWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today their plans to license Pan Am four additional immunotherapy products developed by the Company.

The immune system's natural capacity to detect and destroy abnormal cells may prevent the development of many cancers. However, cancer cells are sometimes able to avoid detection and destruction by the immune system. Cancer cells may:

reduce the expression of tumor antigens on their surface, making it harder for the immune system to detect them
express proteins on their surface that induce immune cell inactivation
induce cells in the surrounding environment (microenvironment) to release substances that suppress immune responses and promote tumor cell proliferation and survival

In the past few years, the rapidly advancing field of cancer immunology has produced several new methods of treating cancer, called immunotherapies, which increase the strength of immune responses against tumors. Immunotherapies either stimulate the activities of specific components of the immune system or counteract signals produced by cancer cells that suppress immune responses.

These advances in cancer immunotherapy are the result of long-term investments in basic research on the immune system research that continues today by scientists at TSOI.




NEWS : 5/31/18

Therapeutic Solutions International to Provide Patients Access to StemVacs Cancer Immunotherapy through Newly Passed Right to Try Law

https://www.nasdaq.com/press-releas...-stemvacs-cancer-immunotherapy-20180531-00698

Therapeutic Solutions International to Provide Patients Access to StemVacs Cancer Immunotherapy through Right to Try Law




volume odierno oltre sei milioni di pezzi scambiati. :cool:



$TSOI 4 CANCER PRODUCTS READY FOR LICENSING, AS 990 MILLION SHARES AS, 800 MILLION OS, ONLY 46 MILLION SHARES IN THE PUBLIC FLOAT, SO FREAKIN THIN
OTC Markets | Official site of OTCQX, OTCQB and Pink Markets
:o:D
 
Ultima modifica:
TSOI Products

8 Biologics, 8 Nutraceuticals, 1 Pharmaceutical = 17

8 Biologics

innaMune Therapeutic Solutions files Patent on Blood Derived Innate Immune System Stimulator
MemoryMune Therapeutic Solutions files Patent on Methods of Re-Activating Dormant Memory Cells with Anticancer Activity
StemVacs StemVacs | Immunotherapy Platform
BRS-001 Therapeutic Solutions International Expands Adoptive Immunotherapy Portfolio by Incorporation of "Universal Cancer Antigen" ...
sRNA augmented stem cells Therapeutic Solutions International Expands Chronic Traumatic Encephalopathy Intellectual Property Portfolio
JadiCell MSCs https://ih.advfn.com/stock-market/U...peutic-solutions-international-signs-agreemen
Autologous Neurogenic Stem Cell Banking http://ih.advfn.com/stock-market/US...peutic-solutions-international-continues-to-e
"Educated" Monocytes / Projenitors https://ih.advfn.com/stock-market/U...peutic-solutions-international-continues-to-e

8 Nutraceuticals

Projuvenol http://projuvenol.com/
NanoStilbene http://nanostilbene.com/
DermalStilbene http://ih.advfn.com/stock-market/US...apeutic-solutions-international-releases-derm
IsoStilbene https://ih.advfn.com/stock-market/U...apeutic-solutions-international-releases-isos
NeuroStilbene https://ih.advfn.com/stock-market/U...erapeutic-solutions-international-inc-release
Alpha Lipoic Acid https://ih.advfn.com/stock-market/U...peutic-solutions-international-develops-micro
Cancer Metabolic DeTox http://www.marketwired.com/press-re...rough-nutraceutical-otc-pink-tsoi-2215015.htm
NanoStilbene w/ PKE
https://ih.advfn.com/stock-market/U...peutic-solutions-international-continues-to-r

1 Pharmaceutical
LymphoBoost http://www.marketwired.com/press-re...munity-mifepristone-otc-pink-tsoi-2217703.htm

4 nutraceutical products for sale online
Projuvenol, NanoStilbene, DermalStilbene (x2)
http://www.youcanordernow.com/

4 Biologics, 3 Nutraceuticals, 1 Pharmaceutical licensed to Pan Am Cancer Treatment Center in Mexico
StemVacs, innaMune, MemoryMune, BRS-001, Cancer Metabolic DeTox, NanoStilbene, IsoStilbene, LymphoBoost

http://ih.advfn.com/p.php?pid=nmona&article=77606645
http://ih.advfn.com/p.php?pid=nmona&article=77309980
http://ih.advfn.com/p.php?pid=nmona&article=77635806
https://ih.advfn.com/stock-market/U...apeutic-solutions-international-releases-isos

Pan Am Cancer Treatment Center Introductory Tour Video
https://www.youtube.com/watch?v=rWgJLRCICa8&feature=youtu.be

TSOI Patents
http://therapeuticsolutionsint.com/?page_id=68
TSOI Patent Search
https://patents.google.com/?assignee=Therapeutic+Solutions+International+Inc

TSOI Scientific Advisory Board Members
https://therapeuticsolutionsint.com/?page_id=64

NEWS 2/19/19

Therapeutic Solutions International Continues to Refine NanoStilbene™ Formulation

NanoStilbene Shown to Reduce Tumor Necrosis Factor-a (TNF-a ) in Cancer Patients
https://ih.advfn.com/stock-market/U...peutic-solutions-international-continues-to-r

OCEANSIDE, CA -- February 19, 2019 -- InvestorsHub NewsWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today further refinement of their patented formulation of nanoparticle pterostilbene known as NanoStilbene™.

NanoStilbene™ is a nanoemulsion of nanoparticle pterostilbene in the 75-90nm (nanometer) range at a concentration of 200mg per milliliter. We have successfully produced the same stable nanoemulsion using peach kernel extract to fortify the NanoStilbene against tumor necrosis factor-a (TNF-a ).

"We recently announced the conclusion of a clinical trial involving 12 advanced, solid tumor, cancer patients who received the equivalence of 300mg's of nanoparticle pterostilbene daily for three weeks which showed on average a 26% decrease in TNF-a 1," said Tim G Dixon CEO & President of Therapeutic Solutions International, Inc. "By adding peach kernel extract to our nanoemulsion formulation we intend to fortify NanoStilbene to be even more effective against high levels of inflammatory cytokines."

"In a recent paper, peach kernel extract has been shown to reduce tissue factor (TF) elevations in atherosclerosis, which is a pathological process in arteries due to plaque formation, by first reducing tumor necrosis factor-a (TNF-a)2," said Dr. Thomas Ichim, Director of Therapeutic Solutions International. "Tumor necrosis factor (TNF) is a type of messenger protein known as a cytokine that is produced by white blood cells. It promotes inflammation, produces other cells used in the inflammatory response, and can help cells heal" added Dr. Ichim.

"By adding the peach kernel extract to the nanoemulsion formulation, our purpose is to open the way for new therapeutic approaches that might eventually decrease the prevalence of tumor necrosis factor-a (TNF-a) in not only cancer patients where TNF-a has been shown to play a key role in these inflammatory processes but also in acute and chronic inflammatory conditions such as trauma, sepsis, infection, rheumatoid arthritis, atherosclerosis, and cardiovascular disease" said Dr. James Veltmeyer, Chief Medical Officer of Therapeutic Solutions International.

TNF-a is a member of a growing family of peptide mediators comprising at least 19 cytokines, including lymphotoxin-, Fas ligand, and CD40 ligand. TNF-a has important proinflammatory properties, which play crucial roles in the innate and adaptive immunity, cell proliferation, and apoptotic processes. The cytokine is produced by different kind of cells, including macrophages, monocytes, T-cells, smooth muscle cells, adipocytes, and fibroblasts.


TSOI NEWS HISTORY 5/1/18 - 1/22/19
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146277441


SHARE STRUCTURE
https://www.otcmarkets.com/stock/TSOI/security

AS - 2.5 B common , 5 M preferred - https://www.nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=LvtIoYTPV6wB1RIovm008A%3d%3d&nt7=0
IO - 1,084,613,182
Restricted - 909,729,214
Unrestricted - 174,883,968
Held at DTC - 152,240,968
Float - 105,109,529

SEC Filings https://www.sec.gov/cgi-bin/browse-...nternational&match=contains&action=getcompany

Transfer Agent
New Horizon Transfer Inc.
215-515 West Pender Street
Vancouver, BC V6B 6H5
CAN(604) 876-5526
www.newhorizontransfer.com

TSOI Management / Board of Directors
https://therapeuticsolutionsint.com/?page_id=62

Contact
Investor Relations
ir@tsoimail.com
Corporate Website
Therapeutic Solutions International, Inc. |
Additional info
http://projuvenol.com/
https://nanostilbene.com/
https://stemvacs.com/
E Commerce Site
www.youcanordernow.com/
TSOI Facebook
https://www.facebook.com/tsoihome/
TSOI Twitter
https://twitter.com/tsoisupplement
https://twitter.com/search?f=tweets&vertical=default&q=$TSOI&src=typd

Disclaimer : All of the information presented in the IBOX , Stickies , or posts on this board , is based on individual opinions , and is not to be considered as a recommendation to buy , sell , or hold this stock .
 
pennystock.es ha scritto:
TSOI Products

8 Biologics, 8 Nutraceuticals, 1 Pharmaceutical = 17

8 Biologics

innaMune Therapeutic Solutions files Patent on Blood Derived Innate Immune System Stimulator
MemoryMune Therapeutic Solutions files Patent on Methods of Re-Activating Dormant Memory Cells with Anticancer Activity
StemVacs StemVacs | Immunotherapy Platform
BRS-001 Therapeutic Solutions International Expands Adoptive Immunotherapy Portfolio by Incorporation of "Universal Cancer Antigen" ...
sRNA augmented stem cells Therapeutic Solutions International Expands Chronic Traumatic Encephalopathy Intellectual Property Portfolio
JadiCell MSCs https://ih.advfn.com/stock-market/U...peutic-solutions-international-signs-agreemen
Autologous Neurogenic Stem Cell Banking http://ih.advfn.com/stock-market/US...peutic-solutions-international-continues-to-e
"Educated" Monocytes / Projenitors https://ih.advfn.com/stock-market/U...peutic-solutions-international-continues-to-e

8 Nutraceuticals

Projuvenol http://projuvenol.com/
NanoStilbene http://nanostilbene.com/
DermalStilbene http://ih.advfn.com/stock-market/US...apeutic-solutions-international-releases-derm
IsoStilbene https://ih.advfn.com/stock-market/U...apeutic-solutions-international-releases-isos
NeuroStilbene https://ih.advfn.com/stock-market/U...erapeutic-solutions-international-inc-release
Alpha Lipoic Acid https://ih.advfn.com/stock-market/U...peutic-solutions-international-develops-micro
Cancer Metabolic DeTox http://www.marketwired.com/press-re...rough-nutraceutical-otc-pink-tsoi-2215015.htm
NanoStilbene w/ PKE
https://ih.advfn.com/stock-market/U...peutic-solutions-international-continues-to-r

1 Pharmaceutical
LymphoBoost http://www.marketwired.com/press-re...munity-mifepristone-otc-pink-tsoi-2217703.htm

4 nutraceutical products for sale online
Projuvenol, NanoStilbene, DermalStilbene (x2)
http://www.youcanordernow.com/

4 Biologics, 3 Nutraceuticals, 1 Pharmaceutical licensed to Pan Am Cancer Treatment Center in Mexico
StemVacs, innaMune, MemoryMune, BRS-001, Cancer Metabolic DeTox, NanoStilbene, IsoStilbene, LymphoBoost

http://ih.advfn.com/p.php?pid=nmona&article=77606645
http://ih.advfn.com/p.php?pid=nmona&article=77309980
http://ih.advfn.com/p.php?pid=nmona&article=77635806
https://ih.advfn.com/stock-market/U...apeutic-solutions-international-releases-isos

Pan Am Cancer Treatment Center Introductory Tour Video
https://www.youtube.com/watch?v=rWgJLRCICa8&feature=youtu.be

TSOI Patents
http://therapeuticsolutionsint.com/?page_id=68
TSOI Patent Search
https://patents.google.com/?assignee=Therapeutic+Solutions+International+Inc

TSOI Scientific Advisory Board Members
https://therapeuticsolutionsint.com/?page_id=64

NEWS 2/19/19

Therapeutic Solutions International Continues to Refine NanoStilbene™ Formulation

NanoStilbene Shown to Reduce Tumor Necrosis Factor-a (TNF-a ) in Cancer Patients
https://ih.advfn.com/stock-market/U...peutic-solutions-international-continues-to-r

OCEANSIDE, CA -- February 19, 2019 -- InvestorsHub NewsWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today further refinement of their patented formulation of nanoparticle pterostilbene known as NanoStilbene™.

NanoStilbene™ is a nanoemulsion of nanoparticle pterostilbene in the 75-90nm (nanometer) range at a concentration of 200mg per milliliter. We have successfully produced the same stable nanoemulsion using peach kernel extract to fortify the NanoStilbene against tumor necrosis factor-a (TNF-a ).

"We recently announced the conclusion of a clinical trial involving 12 advanced, solid tumor, cancer patients who received the equivalence of 300mg's of nanoparticle pterostilbene daily for three weeks which showed on average a 26% decrease in TNF-a 1," said Tim G Dixon CEO & President of Therapeutic Solutions International, Inc. "By adding peach kernel extract to our nanoemulsion formulation we intend to fortify NanoStilbene to be even more effective against high levels of inflammatory cytokines."

"In a recent paper, peach kernel extract has been shown to reduce tissue factor (TF) elevations in atherosclerosis, which is a pathological process in arteries due to plaque formation, by first reducing tumor necrosis factor-a (TNF-a)2," said Dr. Thomas Ichim, Director of Therapeutic Solutions International. "Tumor necrosis factor (TNF) is a type of messenger protein known as a cytokine that is produced by white blood cells. It promotes inflammation, produces other cells used in the inflammatory response, and can help cells heal" added Dr. Ichim.

"By adding the peach kernel extract to the nanoemulsion formulation, our purpose is to open the way for new therapeutic approaches that might eventually decrease the prevalence of tumor necrosis factor-a (TNF-a) in not only cancer patients where TNF-a has been shown to play a key role in these inflammatory processes but also in acute and chronic inflammatory conditions such as trauma, sepsis, infection, rheumatoid arthritis, atherosclerosis, and cardiovascular disease" said Dr. James Veltmeyer, Chief Medical Officer of Therapeutic Solutions International.

TNF-a is a member of a growing family of peptide mediators comprising at least 19 cytokines, including lymphotoxin-, Fas ligand, and CD40 ligand. TNF-a has important proinflammatory properties, which play crucial roles in the innate and adaptive immunity, cell proliferation, and apoptotic processes. The cytokine is produced by different kind of cells, including macrophages, monocytes, T-cells, smooth muscle cells, adipocytes, and fibroblasts.


TSOI NEWS HISTORY 5/1/18 - 1/22/19
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146277441


SHARE STRUCTURE
https://www.otcmarkets.com/stock/TSOI/security

AS - 2.5 B common , 5 M preferred - https://www.nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=LvtIoYTPV6wB1RIovm008A%3d%3d&nt7=0
IO - 1,084,613,182
Restricted - 909,729,214
Unrestricted - 174,883,968
Held at DTC - 152,240,968
Float - 105,109,529

SEC Filings https://www.sec.gov/cgi-bin/browse-...nternational&match=contains&action=getcompany

Transfer Agent
New Horizon Transfer Inc.
215-515 West Pender Street
Vancouver, BC V6B 6H5
CAN(604) 876-5526
www.newhorizontransfer.com

TSOI Management / Board of Directors
https://therapeuticsolutionsint.com/?page_id=62

Contact
Investor Relations
ir@tsoimail.com
Corporate Website
Therapeutic Solutions International, Inc. |
Additional info
http://projuvenol.com/
https://nanostilbene.com/
https://stemvacs.com/
E Commerce Site
www.youcanordernow.com/
TSOI Facebook
https://www.facebook.com/tsoihome/
TSOI Twitter
https://twitter.com/tsoisupplement
https://twitter.com/search?f=tweets&vertical=default&q=$TSOI&src=typd

Disclaimer : All of the information presented in the IBOX , Stickies , or posts on this board , is based on individual opinions , and is not to be considered as a recommendation to buy , sell , or hold this stock .
Clicca per espandere...



OK!:clap::clap::clap:
 
"We are getting close to wrapping up our buildout of new production labs at TSOI HQ. This, of course, will allow us to control our own destiny without jeopardizing our proprietary processes by utilizing 3rd party manufacturing. Look for many new exciting specialty products to come from these facilities including combination compounds such as pterostilbene and cannabidiol, pterostilbene and alpha-lipoic-acid, pterostilbene and huperzine, all in nanoparticle formulations. Stay tuned we've only just begun."


Therapeutic Solutions International, Inc. - Accueil | Facebook
 
Devi accedere o registrarti per poter rispondere.
Indietro